Clinical Trial Update: A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938) [Phase 3]

View source ↗

Summary

Phase 3 trial of preladenant in moderate to severe Parkinson's disease completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• preladenant (preladenant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-02-11